Observational Clinical Trial
Official title:
An Observational Phase II Trial of Targeted Next Generation Sequencing Analysis for the Efficacy of Trastuzumab Neoadjuvant Chemotherapy in Patients With HER2 Positive Breast Cancer
To explore the genetic background of patients with HER2 positive breast cancer that benefit from trastuzumab combined with neoadjuvant chemotherapy, identify clinically actionable mutations that associated with trastuzumab resistance or drug efficacy, we designed this Observational phase II trial. The primary endpoint is genetic profile of HER2+ breast cancer patients treated with trastuzumab combined neoadjuvant chemotherapy. Secondary endpoints included pathological complete response (pCR) rate and safety.
Currently, patients with stage II-III breast cancer still accounts for a large population in China, and neoadjuvant therapy is considered the standard treatment for them. The pathological complete response (pCR) rate takes for an indicator for regimens efficacy, and the achievement of pCR after neoadjuvant chemotherapy is associated with favorable outcomes including disease-free survival and overall survival. HER2+ breast cancer represents an invasive and poor prognosis subtype, and the efficacy of neoadjuvant therapy for these patients has been greatly augmented by the addition of trastuzumab. However, more than 50% of HER2+ breast cancer patients treated with trastuzumab combined neoadjuvant chemotherapy cannot achieve pCR, even experience primary drug resistance and rapid disease progression. Therefore, to explore the genomic features of the population that benefited from trastuzumab combined with chemotherapy is of great significance for personalized treatment of HER2+ breast cancer, aiming to avoid overtreatment and identify clinically actionable mutations for future therapy instructions. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT01168570 -
Progression of Renal Amyloidosis of FMF and Relation to Serum SAA Level
|
N/A | |
Completed |
NCT03548753 -
Use of FFR-CT in Stable Intermediate Chest Pain Patients With Severe Coronary Calcium Score
|
||
Completed |
NCT03138772 -
Tracking CF Lung Disease Through the Early Years: Utility of the LCI
|
||
Completed |
NCT00233649 -
DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European Guidelines
|
Phase 4 | |
Completed |
NCT06433154 -
Arthroscopy of the Temporomandibular Joint. On Jaw Mobility, Pain and HRQoL
|
||
Not yet recruiting |
NCT06448715 -
Real-World Treatment Study of Soliris (Eculizumab)
|
||
Completed |
NCT00745966 -
Atypical Antipsychotics in Improvement of Quality of Life in Bipolar Disorder
|
N/A | |
Recruiting |
NCT03253536 -
Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma
|
N/A | |
Not yet recruiting |
NCT05693714 -
Adenovirus Infection in Children With Autoimmune Hepatitis
|
||
Completed |
NCT02922205 -
Stapler Post-market Observational Study
|